Monday April 6, 2020

New drugs help Pfizer beat expectations

Sales of breast cancer treatment more than tripled in Q2

2nd August, 2016
Pfizer employs around 3,000 in Ireland Pic: RollingNews.ie

Pharmaceutical giant Pfizer has reported second-quarter earnings that beat analysts’ estimates, thanks to strong sales of its newest drugs for cancer and rheumatoid arthritis.

Sales of Ibrance, Pfizer’s new breast cancer treatment, more than tripled to $514m. The drug generated $723m last year, its first on the market, and analysts surveyed by Bloomberg predict annual sales will reach $4.81 billion by 2018.

Second-quarter sales of Pfizer’s rheumatoid arthritis drug Xeljanz were $217m, ahead of...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

Every time Donald Trump spoke on the Covid-19 crisis last week, the stock markets plunged by another point

Marion McKeone | 3 weeks ago

Big tech firms pledge to pay contract staff through the social-distancing period

Emmet Ryan | 3 weeks ago

Further action may be needed to prevent the Irish economy being sunk, particularly when the global economy remains vulnerable

Ian Guider | 3 weeks ago